November 9-11, 2020 | Virtual Conference


Edwin Jao, PhD

Director, Division of Pharmaceutical Manufacturing Assessment 3, Office of Pharmaceutical Manufacturing Assessment (OPMA), OPQ, CDER

Edwin Jao is the division director for FDA/CDER/Office of Product Quality (OPQ)/Office of Pharmaceutical Assessment (OPMA), overseeing process and facility reviews for ANDAs, NDAs, and IND meeting packages. He joined the FDA in 2003 as a CMC reviewer, after a career in major pharmaceutical industries with increased responsibilities. Edwin received his Ph.D. degree in medicinal chemistry from Rutgers University.

Skip to content